Resectoscope or Versapoint for hysteroscopic metroplasty

Area of Science:

• Reproductive Medicine
• Minimally Invasive Surgery
• Gynecology

Background:

• Uterine septum is a common congenital anomaly affecting reproductive outcomes.
• Hysteroscopic metroplasty is the standard surgical treatment for uterine septum.
• Different hysteroscopic devices exist for uterine septum resection.

Purpose of the Study:

• To compare the feasibility, safety, and reproductive outcomes of hysteroscopic metroplasty using the Versapoint device versus the resectoscope.
• To evaluate operative time and complication rates between the two hysteroscopic techniques.

Main Methods:

• A comparative study of 63 women with partial septate uterus.
• Forty-two women underwent hysteroscopic metroplasty with Versapoint; 21 with resectoscope.
• Key outcomes included operating time, complications, pregnancy rate, and delivery mode.

Main Results:

• Versapoint group had a significantly shorter operating time (15.4 min) compared to the resectoscope group (20.5 min).
• Pregnancy rates, delivery rates, and spontaneous abortion rates were similar between the Versapoint and resectoscope groups.
• The Versapoint technique did not require cervical dilation, reducing risks of incompetence and laceration.

Conclusions:

• Hysteroscopic metroplasty with Versapoint is a safe and effective alternative to the resectoscope.
• Versapoint offers advantages by avoiding cervical dilation, thus preventing cervical incompetence and lacerations.
• This technique is particularly suitable for nulligravida women, especially those with cervical stenosis.